This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors
Zumutor Biologics Inc.
Zumutor Biologics Inc.
Hoffmann-La Roche
University Hospital Southampton NHS Foundation Trust
Memorial Sloan Kettering Cancer Center
Shenyang Sunshine Pharmaceutical Co., LTD.
Sun Yat-sen University
Sun Yat-sen University
Sun Yat-sen University
H. Lee Moffitt Cancer Center and Research Institute
Children's Oncology Group
Pfizer
Groupe Oncologie Radiotherapie Tete et Cou
H. Lee Moffitt Cancer Center and Research Institute
Genentech, Inc.
Hoffmann-La Roche
Hoffmann-La Roche
Takeda
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital